Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Stereotactic Surgery Devices Market by Type (Gamma Knife, Proton Beam, Line Accelerator Machines), By Application (Brain Tumor Treatment, Arteriovenous Malformations Treatment, Trigeminal Neuralgia, Parkinsons Disease, Epilepsy) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Stereotactic Surgery Devices Market by Type (Gamma Knife, Proton Beam, Line Accelerator Machines), By Application (Brain Tumor Treatment, Arteriovenous Malformations Treatment, Trigeminal Neuralgia, Parkinsons Disease, Epilepsy) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137121 3300 Medical Devices & Consumables 377 239 Pages 4.8 (48)
                                          

Global Stereotactic Surgery Devices Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030 from USD 2.3 billion in 2018. The market is driven by factors such as increasing prevalence of neurological disorders and rising demand for minimally invasive surgical procedures. The global market for stereotactic surgery devices was valued at USD 2.3 billion in 2018 and is projected to reach USD 3.2 billion by 2030, growing at a CAGR of 5.5% during the forecast period from 2021-2030. The market has been segmented on the basis of type into gamma knife, proton beam, and line accelerator machines; application into brain tumor treatment, arteriovenous malformations treatment, trigeminal neuralgia (TN), Parkinson’s disease (PD), and epilepsy; and region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific & Middle East & Africa (APMEA). -The global Stereotactic Surgery Devices market is expected to grow at a CAGR of 5.5% during the forecast period, 2018-2025. -The global Stereotactic Surgery Devices market is expected to reach USD 3.2 billion by 2025 from USD 2.1 billion in 2018, growing at a CAGR of 5.5%. -Increasing prevalence of neurological disorders such as Parkinson’s disease and Alzheimer’s disease are driving the growth of the global Stereotactic Surgery Devices market. -Increasing number of neurosurgeons and neurologists are also driving the growth of the global Stereotactic Surgery Devices market due to increasing demand for minimally invasive procedures for brain tumors and other neurological disorders such as Parkinson’s disease and Alzheimer’s disease which require less recovery time than traditional surgeries. -Growing geriatric population base is also driving the growth of this market due to increasing incidence rates for neurological disorders among elderly people with age related cognitive decline or dementia which requires surgical intervention in order to treat them effectively without causing any further damage or deterioration in their condition.

Industry Growth Insights published a new data on “Stereotactic Surgery Devices Market”. The research report is titled “Stereotactic Surgery Devices Market research by Types (Gamma Knife, Proton Beam, Line Accelerator Machines), By Applications (Brain Tumor Treatment, Arteriovenous Malformations Treatment, Trigeminal Neuralgia, Parkinsons Disease, Epilepsy), By Players/Companies CIRS, IBA, Inomed, Elekta AB, Micromar, adeor Medical AG, Alliance Oncology, Monteris Medical, Modus Medical Devices, Raysearch Laboratories”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Stereotactic Surgery Devices Market Research Report

By Type

Gamma Knife, Proton Beam, Line Accelerator Machines

By Application

Brain Tumor Treatment, Arteriovenous Malformations Treatment, Trigeminal Neuralgia, Parkinsons Disease, Epilepsy

By Companies

CIRS, IBA, Inomed, Elekta AB, Micromar, adeor Medical AG, Alliance Oncology, Monteris Medical, Modus Medical Devices, Raysearch Laboratories

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

239

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Stereotactic Surgery Devices Industry Outlook


Global Stereotactic Surgery Devices Market Report Segments:

The global Stereotactic Surgery Devices market is segmented on the basis of:

Types

Gamma Knife, Proton Beam, Line Accelerator Machines

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Brain Tumor Treatment, Arteriovenous Malformations Treatment, Trigeminal Neuralgia, Parkinsons Disease, Epilepsy

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. CIRS
  2. IBA
  3. Inomed
  4. Elekta AB
  5. Micromar
  6. adeor Medical AG
  7. Alliance Oncology
  8. Monteris Medical
  9. Modus Medical Devices
  10. Raysearch Laboratories

Global Stereotactic Surgery Devices Market Overview


Highlights of The Stereotactic Surgery Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Gamma Knife
    2. Proton Beam
    3. Line Accelerator Machines
  1. By Application:

    1. Brain Tumor Treatment
    2. Arteriovenous Malformations Treatment
    3. Trigeminal Neuralgia
    4. Parkinsons Disease
    5. Epilepsy
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Stereotactic Surgery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Stereotactic Surgery Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Stereotactic surgery devices are medical tools that allow for precise placement of surgical instruments inside the body. This technology is often used to treat conditions such as cancer, epilepsy, and brain tumors.

Some of the major players in the stereotactic surgery devices market are CIRS, IBA, Inomed, Elekta AB, Micromar, adeor Medical AG, Alliance Oncology, Monteris Medical, Modus Medical Devices, Raysearch Laboratories.

The stereotactic surgery devices market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Stereotactic Surgery Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Stereotactic Surgery Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Stereotactic Surgery Devices Market - Supply Chain
   4.5. Global Stereotactic Surgery Devices Market Forecast
      4.5.1. Stereotactic Surgery Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Stereotactic Surgery Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Stereotactic Surgery Devices Market Absolute $ Opportunity

5. Global Stereotactic Surgery Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Stereotactic Surgery Devices Market Size and Volume Forecast by Type
      5.3.1. Gamma Knife
      5.3.2. Proton Beam
      5.3.3. Line Accelerator Machines
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Stereotactic Surgery Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Stereotactic Surgery Devices Market Size and Volume Forecast by Application
      6.3.1. Brain Tumor Treatment
      6.3.2. Arteriovenous Malformations Treatment
      6.3.3. Trigeminal Neuralgia
      6.3.4. Parkinsons Disease
      6.3.5. Epilepsy
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Stereotactic Surgery Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Stereotactic Surgery Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Stereotactic Surgery Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Stereotactic Surgery Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Stereotactic Surgery Devices Demand Share Forecast, 2019-2029

9. North America Stereotactic Surgery Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Stereotactic Surgery Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Stereotactic Surgery Devices Market Size and Volume Forecast by Application
      9.4.1. Brain Tumor Treatment
      9.4.2. Arteriovenous Malformations Treatment
      9.4.3. Trigeminal Neuralgia
      9.4.4. Parkinsons Disease
      9.4.5. Epilepsy
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Stereotactic Surgery Devices Market Size and Volume Forecast by Type
      9.7.1. Gamma Knife
      9.7.2. Proton Beam
      9.7.3. Line Accelerator Machines
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Stereotactic Surgery Devices Demand Share Forecast, 2019-2029

10. Latin America Stereotactic Surgery Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Stereotactic Surgery Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Stereotactic Surgery Devices Market Size and Volume Forecast by Application
      10.4.1. Brain Tumor Treatment
      10.4.2. Arteriovenous Malformations Treatment
      10.4.3. Trigeminal Neuralgia
      10.4.4. Parkinsons Disease
      10.4.5. Epilepsy
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Stereotactic Surgery Devices Market Size and Volume Forecast by Type
      10.7.1. Gamma Knife
      10.7.2. Proton Beam
      10.7.3. Line Accelerator Machines
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Stereotactic Surgery Devices Demand Share Forecast, 2019-2029

11. Europe Stereotactic Surgery Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Stereotactic Surgery Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Stereotactic Surgery Devices Market Size and Volume Forecast by Application
      11.4.1. Brain Tumor Treatment
      11.4.2. Arteriovenous Malformations Treatment
      11.4.3. Trigeminal Neuralgia
      11.4.4. Parkinsons Disease
      11.4.5. Epilepsy
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Stereotactic Surgery Devices Market Size and Volume Forecast by Type
      11.7.1. Gamma Knife
      11.7.2. Proton Beam
      11.7.3. Line Accelerator Machines
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Stereotactic Surgery Devices Demand Share, 2019-2029

12. Asia Pacific Stereotactic Surgery Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Stereotactic Surgery Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Stereotactic Surgery Devices Market Size and Volume Forecast by Application
      12.4.1. Brain Tumor Treatment
      12.4.2. Arteriovenous Malformations Treatment
      12.4.3. Trigeminal Neuralgia
      12.4.4. Parkinsons Disease
      12.4.5. Epilepsy
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Stereotactic Surgery Devices Market Size and Volume Forecast by Type
      12.7.1. Gamma Knife
      12.7.2. Proton Beam
      12.7.3. Line Accelerator Machines
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Stereotactic Surgery Devices Demand Share, 2019-2029

13. Middle East & Africa Stereotactic Surgery Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Stereotactic Surgery Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Stereotactic Surgery Devices Market Size and Volume Forecast by Application
      13.4.1. Brain Tumor Treatment
      13.4.2. Arteriovenous Malformations Treatment
      13.4.3. Trigeminal Neuralgia
      13.4.4. Parkinsons Disease
      13.4.5. Epilepsy
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Stereotactic Surgery Devices Market Size and Volume Forecast by Type
      13.7.1. Gamma Knife
      13.7.2. Proton Beam
      13.7.3. Line Accelerator Machines
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Stereotactic Surgery Devices Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Stereotactic Surgery Devices Market: Market Share Analysis
   14.2. Stereotactic Surgery Devices Distributors and Customers
   14.3. Stereotactic Surgery Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. CIRS
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. IBA
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Inomed
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Elekta AB
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Micromar
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. adeor Medical AG
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Alliance Oncology
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Monteris Medical
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Modus Medical Devices
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Raysearch Laboratories
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us